Global Viral Gastroenteritis Market Insights Forecasts to 2032

• The Global Viral Gastroenteritis Market Size was valued at USD 6.3 Billion in 2022.
• The Market is Growing at a CAGR of 4.1% from 2022 to 2032.
• The Worldwide Viral Gastroenteritis Market size is expected to reach USD 9.5 Billion by 2032.
• Asia Pacific is expected to Grow the fastest during the forecast period.

Get more details on this report -

Request Free Sample PDF

The Global Viral Gastroenteritis Market Size is expected to reach USD 9.5 Billion by 2032, at a CAGR of 4.1% during the forecast period 2022 to 2032. The introduction of novel goods by manufacturers and an expanding patient pool are projected to propel the gastrointestinal infection testing market forward over the forecast period. Furthermore, there is a rising demand for novel drugs to treat the disease.

 

Market Overview

Viral gastroenteritis is a prevalent gastrointestinal ailment that affects people worldwide. The lining of the stomach, small intestine, and large intestine are irritated by viral gastroenteritis, often known as stomach flu. Viral gastroenteritis is caused by a variety of viruses such as norovirus, rotavirus, astrovirus, and enteric adenovirus are among the viruses that cause viral gastroenteritis. This disease is spread through direct contact with the sufferer as well as contaminated water or food. The primary objective of treatment is to rehydrate the patient by drinking enough water or fluids symptoms of this disease include abdominal pain, disorientation, diarrhea, nausea, vomiting, headache, chills, loss of appetite, fever, joint stiffness, sweating, muscular soreness, and weight loss, among others.

 

Report Coverage

This research report categorizes the global viral gastroenteritis market based on various segments and regions and forecasts revenue growth and analyses trends in each submarket. The report analyses the key growth drivers, opportunities, and challenges influencing the global viral gastroenteritis market. Recent market developments and competitive strategies such as expansion, product launch, and development, partnership, merger, and acquisition have been included to draw the competitive landscape in the market. The report strategically identifies and profiles the key market players and analyses their core competencies in each sub-segment of the global viral gastroenteritis market. Technological innovation and advancement will further optimize the performance of the product, enabling it to acquire a wider range of applications in the downstream market.

 

Driving Factors

The key variables affecting the market growth rate are the rising prevalence of gastrointestinal illnesses and rising healthcare spending. In addition, to the growing elderly population, new product launches drive the market growth of the viral gastroenteritis market. Similarly, additional factors such as increased urbanization and greater health knowledge would have a beneficial impact on the market growth rate. Also, an increase in research and development activities may drive the growth of the global viral gastroenteritis market. Moreover, during the projection period, an increase in the number of pipeline drugs and clinical studies on rare conditions would give advantageous possibilities for the viral gastroenteritis market. Furthermore, the rising attempts by public and private organizations to raise awareness about the condition and its preventive measures will drive the viral gastroenteritis

 

Restraining Factors

The high cost of treatment, complications connected with the disease such as severe dehydration, and the large initial investment required in research and development activities for the enhancement of vaccines, medications, and treatment kits are the factors that will stymie market expansion. Also, the stringent regulations imposed on the treatment and use of chemicals in medicine manufacturing procedures may provide additional challenges to the viral gastroenteritis market during the projection period. In addition, a lack of awareness in the population globally may also restrict the growth of the global viral gastroenteritis market.

 

Market Segmentation

• In 2022, the global viral gastroenteritis market, By Type of Virus

The global viral gastroenteritis market is segmented into norovirus, and rotavirus based on the type of virus.

 

• In 2022, the global viral gastroenteritis market, By Diagnosis

Based on the diagnosis, the global viral gastroenteritis market is divided into physical examination, rapid stool tests, and others.

 

• In 2022, the global viral gastroenteritis market, By Drugs

On the basis of drugs, the global viral gastroenteritis market is segmented into Antibiotics, Antacids, Laxatives, and antimotility Agents.

 

• In 2022, the hospital segment is driving market share growth during the forecast period.

On the basis of end users, the global viral gastroenteritis market is segmented into clinics, hospitals, and others. Among these, the hospital is expected to grow the market during the forecast period, because they have access to specific technology and knowledge required for hysteroscopy and other diagnostic procedures. Furthermore, hospitals usually have a higher patient volume and are more likely to receive referrals from primary care practitioners, which may contribute to their dominance in this category.

 

Regional Segment Analysis of the viral gastroenteritis market

• North America (U.S., Canada, Mexico) 
• Europe (Germany, France, U.K., Italy, Spain, Rest of Europe)
• Asia-Pacific (China, Japan, India, Rest of APAC)
• South America (Brazil and the Rest of South America) 
• The Middle East and Africa (UAE, South Africa, Rest of MEA)

 

North America is holding the market with the largest market share over the forecast period

 

Get more details on this report -

Request Free Sample PDF

North America is the largest market for viral gastroenteritis owing to the rising prevalence of viral gastroenteritis in the U.S., especially among the pediatric population. According to the Centers for Disease Control and Prevention (CDC), there are approximately 19 to 21 million number of acute gastroenteritis in the United States annually. Moreover, the rising awareness about diseases, and health-related problems arising due to the presence of major key players, in viral gastroenteritis. Also, the well-developed healthcare infrastructure in this region may hold the largest market share during the forecast period.

 

Asia Pacific is expected to register significant revenue growth during the forecast period, due to the increased research and development activities, rising demand for quick diagnostic tests for gastrointestinal illnesses. Also, expanding awareness about various treatment options grow the market share of viral gastroenteritis. In addition, and rising investments in life science research and demand for innovative medicines for the treatment of gastrointestinal illnesses in developing countries such as China and India will boost the Asia Pacific market forward.

 

Competitive Analysis

The report offers the appropriate analysis of the key organizations/companies involved within the global viral gastroenteritis market along with a comparative evaluation primarily based on their product offering, business overviews, geographic presence, enterprise strategies, segment market share, and SWOT analysis. The report also provides an elaborative analysis focusing on the current news and developments of the companies, which includes product development, innovations, joint ventures, partnerships, mergers & acquisitions, strategic alliances, and others. This allows for the evaluation of the overall competition within the market.

 

List of Key Companies

• Pfizer Inc.
• GlaxoSmithKline plc
• Sanofi
• Novartis AG
• Sun Pharmaceutical Industries Ltd.
• Johnson & Johnson Private Ltd.
• Allergan
• AstraZeneca, Bausch Health Companies Inc.
• Takeda Pharmaceutical Company Ltd.
• Mylan N.V.
• Teva Pharmaceutical Industries Ltd.
• Aurobindo Pharma
• Lupin
• Fresenius Kabi AG
• Zydus Cadila
• Merck Sharp & Dohme Corp.
• Eli Lilly and Company
• Bristol-Myers Squibb Company
• Cipla Inc., Astellas Pharma Inc.
• Abbott
• Dr. Reddy’s Laboratories Ltd.

 

Key Target Audience

• Market Players
• Investors
• End-users
• Government Authorities 
• Consulting And Research Firm
• Venture capitalists
• Value-Added Resellers (VARs)

 

Market Segment

This study forecasts revenue at global, regional, and country levels from 2022 to 2032. Spherical Insights has segmented the Global Viral Gastroenteritis Market based on the below-mentioned segments:

 

Global Viral Gastroenteritis Market, By Type of Virus

• Norovirus
• Rotavirus

 

Global Viral Gastroenteritis Market, By Diagnosis

• Physical Examination
• Rapid Stool Test
• Others

 

Global Viral Gastroenteritis Market, By Drugs

• Antibiotics
• Antacids
• Laxatives
• Antimotility Agents

 

Global Viral Gastroenteritis Market, By End Users

• Clinic
• Hospital
• Others

 

Viral Gastroenteritis Market, By Regional Analysis

• North America
  • US
  • Canada
  • Mexico

• Europe
  • Germany
  • Uk
  • France
  • Italy
  • Spain
  • Russia
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Rest of Asia Pacific
• South America
  • Brazil
  • Argentina
  • Rest of South America
• Middle East & Africa
  • UAE
  • Saudi Arabia
  • Qatar
  • South Africa
  • Rest of Middle East & Africa